“TECHNICAL AND PATENT PERSPECTIVE ON FILM FORMING TOPICAL SPRAYS”

Authors

  • M. H. DEHGHAN Department of Pharmaceutics, Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad-431003, Maharashtra, India https://orcid.org/0000-0002-8082-9454
  • SailiSAILI P. RAJPUT Department of Pharmaceutics, Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad-431003, Maharashtra, India https://orcid.org/0000-0002-6458-9825

DOI:

https://doi.org/10.22159/ijpps.2024v16i12.52109

Keywords:

Film Forming Agents, Film forming systems, Patented Formulations, Skin Infections, Topical Drug Delivery System, Transdermal sprays, Anti-Fungal agents, Sustained Drug Release

Abstract

Film-forming systems were a viable option for topical and transdermal medication administration in the present study. Medication administered via the skin serves two purposes: topical treatment of skin disorders and transdermal drug absorption into the circulation. Apart from the ease of self-administration, the topical route provides a broad and diverse surface and functions as a substitute for oral and hypodermic injection drug delivery routes. Existing dosage forms, such as creams, patches, and ointments, have several drawbacks. In addition to being unsightly, patches can be painful to put on curved surfaces, create discomfort while peeling off, and most often cause skin irritation because of their occlusive qualities, which block sweat ducts and prevent perspiration from evaporating from the skin surface. This review encompasses the mechanism of polymers, such as ethyl cellulose and Eudragit types, plasticizers, and penetration enhancers utilized in film formation. Overall, polymeric film-forming sprays exhibit substantial potential for the convenient administration of antibiotics and antiseptics to treat bacterial, fungal, and viral skin infections. The application of topical medication is thought to result in both local and systemic effects. The physicochemical characteristics of the medication and patient adherence determine how well the topical treatment works. Poor permeability and poor adherence to the skin are some of the disadvantages of conventional pharmaceutical formulations for topical and dermatological administration. The development of medication delivery technologies intended for topical administration to the skin includes the use of topical film-forming systems.

Downloads

Download data is not yet available.

References

Boer M, Duchnik E, Maleszka R, Marchlewicz M. Structural and Biophysical Characteristics of Human skin in Maintaining Proper epidermal barrier functions. Postepy Dermatol Alergol. 2016; 33(1):1-5. Doi: 10.5114/pdia.2015.48037, PMID 26985171.

Jenkins G, Tortora GJ. Anatomy and physiology. John Wiley & Sons; 2016 May 3.

Ki V, Rotstein C. Bacterial Skin and Soft Tissue Infection in Adults: a review of their epidemiology, pathogenesis, Diagnosis, Treatment and Site of care. Can J Infect Dis Med Microbial. 2008; 19(2): Article ID 846453. Doi: 10.1155/2008/846453, PMID 19352449.

Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 39(3):309–317. doi: 10.1086/421946

Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. 2019. Twenty years of the SENTRY antifungal surveillance program: Results for Candida species from 1997-2016. Open Forum Infect Dis. 6(Suppl 1):s79–s94. doi: 10.1093/ofid/ ofy358.

González LM, Ruder WC, Mitchell AP, Messner WC, Leduc PR. 2015. Sudden motility reversal indicates sensing of magnetic field gradients in Magnetospirillum magneticum AMB-1 strain. ISME J. 9(6):1399–1409. doi: 10.1038/ismej.2014.224.

Vishwakarma G, Panwar As. Emulgel emergent systems: at a glance for topical drug delivery. Asian J Pharm Clin Res. 2022; 15(3):8-14.

Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery in Asian journal of Pharmaceutical Research; 2016. P. 4-5.

Abd, Umar K. Film Forming Spray for topical drug delivery article in drug design development and therapy; Jul 2020. P. 4-5.

Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB. Spray Film-Forming systems as promising topical in situ Systems: A review. Saudi Pharm J. 2023 Jan;31(1):154-169. doi: 10.1016/j.jsps.2022.11.014. Epub 2022 Nov 23. PMID: 36685308; PMCID: PMC9845128.

Nitin Merubhai Mori , Priya Patel , Navin R. Sheth , Lalji V. Rathod , Kalpesh Chhotalal Ashara, Fabrication and characterization of film-forming Voriconazole transdermal spray for the treatment of fungal infection, Bulletin of Faculty of Pharmacy, Cairo University,2017, 55(2017) 41-51

Manam M, rao M. Prasad. Topical Spray Formulation Glycopyrrolate US 20190099344 A1 April 2019.

Takruri H. Chavers. Flurandrenolide film formation. US4210633. A July 1980.

Tillmann K, Jonatham K. An Aqueous Antimicrobial film forming composition for teat treatment by spray application. WO2016/206729 A1. December 2016.

Amar L. Topical spray. WO00/45795. August 2000.

Fahim, Ahmed U. Barrier film forming composition and methods of use. US 8,778,369 B2. July 2014.

Mc Entire Edward Enns. Water dispersible films for delivery of active agents to the epidermis. US2007/0258935 A1 November 2007.

Saafir A, Hajduk D. Water resistant film forming composition incorporating hydrophilic activities. US2007/0238807 A1. October 2007.

Paul. A, Sarkar.A. Topical film delivery system. US 20170049789 A1. February 2017.

Kottayeil. S, Kumar.A. Topical film forming spray. US2022/0133642 A1. May 2022.

Edith M. Anti-acne topical films. US 20140271931. 2014; A1 (September).

George K, Kumar. A, Topical film forming spray. EP 3 380. 2021; B1 (September):080.

Laurent.P. Film forming composition for spraying on the skin. US 6,325,990 B1. December 2001.

Raut. P, Malhotra. G Topical sprays comprising A Film forming composition. EP 1 150. 2003; B1 (October):661.

Hardy.C Film forming composition. US 9,782,514 B2 October 2017.

Suzuki H. Protective film forming spray for skin surface.US 2021/0330509 A1.

Halloran D, Yelena Z. Film forming composition for topical use and delivery of active ingredients. US 6,797,262 B2. September 2004.

Israel D. John Kuleza Therapeutic film forming composition and treatment system therefor US 20040071760. Vol. A1 (April); 2004.

Luppo Edens B, N. Topical Application of enzymes using a peelable film. US 20010006675. 2001; A1 (July).

Celestino R. Topical composition for covering a skin lesion. EP 1 179. 2002; A1 (February):352.

Thomas X. Topical Compositions WO 2012/09575 A2.

John M, Neville J. Improvement in Therapeutic composition for topical application 1213295; November 1970.

Das D, Vizzotli E. Topical analgesic composition US2020/0345696 A1. November 2020.

Claire B. Topical film forming composition and use thereof for treating Mycosis. US2014/0128468 A1. May 2014.

Kendel N. Film Forming liquid composition. EP 1 321. 2003; A1 (June):137.

Amar M. Topical Pharmaceutical composition WO 2009/101412. Vol. A1 (August); 2009.

Karen c. Non-leaching surface active film compositions for microbial adhesion prevention. 2007; A1 (July):CA2636975.

Lozinsky E. Composition for the treatment of Epistaxis. WO2016/178053 A1. November 2016.

Film forming solutions of copolymers of N-vinyl pyrrolidone and N-vinyl ester 820,970; February 1960.

Troyano N. In situ Film forming composition WO 2022/234081. Vol. A1; November 2022.

Dandiker Y, Panchal M. Testosterone Transdermal spray with film. WO2019/140087 A1 July 2019.

Russell M, Jay M. Ph-sensitive mucoadhesive film forming gels and wax film composites suitable for topical and mucosal delivery of molecules. WO02/051382 A2 July 2002.

Sapkal P, Davel L. Pharmaceutical micro emulsion immobilized in a thin polymer matrix and method of making them. WO2015/107544 A2. July 2015.

Inorie E, Jmaes. Film forming composition for topical use. WO86/07255 December 1986.

Barry Brown A. Topical film forming Monophasic formulation. NZ567022 A June 2011.

David K. Water resistant film forming antimicrobial skin preparation. 2001; B1 (May):US6228354.

Wilson L. Sprayable film forming composition for improving the performance of topical preparation. 2021; B1 (September):US11129788.

Kim B. Agent for forming film on skin US2021/0361556 A1. November 2021.

Cho CW, Kim DB, Shin SC. Development of bioadhesive transdermal bupivacaine gels for enhanced local anaesthetic action. Iran J Pharm Res. 2012 spring; 11(2):423-31. PMID 24250466, PMCID PMC3832163.

Paradkar M, Thakkar V, Soni T, Gandhi T, Gohel M. Formulation and evaluation of clotrimazole transdermal spray. Drug Dev Ind Pharm. 2015; 41(10):1718-25. doi: 10.3109/03639045.2014.1002408. PMID 25579237.

Etodolac topical spray films, development, characterization and in-vitro evaluation. Int J Pharm Res. 2020

Dhimmar B, Pokale R, Rahamathulla M, Hani U, Alshahrani MY, Alshehri SM et al. Newfangled topical film-forming solution for facilitated antifungal therapy: design, development, characterization, and in vitro evaluation. Polymers. 2023; 15(4). Doi: 10.3390/polym15041003, PMID 36850286.

Desai MN, Godbole AM, Somnache SN, Gajare PS, Pednekar AS, Manerikar S et al. Design, development, and characterization of film forming spray as novel antifungal topical formulation for superficial fungal infections. Indian J Pharm Educ Res. 2022; 56(4s):s651-8. Doi: 10.5530/ijper.56.4s.211.

Sritharadol R, Nakpheng T, Wan Sia Heng P, Srichana T. Development of a topical Mupirocin spray for antibacterial and wound-healing applications. Drug Dev Ind Pharm. 2017; 43(10):1715-28. Doi: 10.1080/03639045.2017.1339077, PMID 28581830.

Bakshi A, Bajaj AN, Malhotra G, Madan M, Amrutiya N. A novel metered dose transdermal spray formulation for oxybutynin. Indian J Pharm Sci. 2008; 70(6):733-9. Doi: 10.4103/0250-474X.49094, PMID 21369433.

Chamsai B, Soodvilai S, Opanasopit P, Samprasit W. Topical film-forming chlorhexidine gluconate sprays for antiseptic application. Pharmaceutics. 2022; 14(6). Doi: 10.3390/pharmaceutics14061124, PMID 35745696.

Abdullah N, Patil AB. Designing of novel topical in situ polymeric film-forming solution spray formulation of antifungal agent: in vitro activity and in vivo characterization. Int J Appl Pharm. 2022:169-84. Doi: 10.22159/ijap.2022v14i1.43581.

Gohel MC, Nagori SA. Fabrication of modified transport fluconazole transdermal spray containing ethyl cellulose and Eudragit® RS100 as film formers. AAPS PharmSciTech. 2009; 10(2):684-91. Doi: 10.1208/s12249-009-9256-8, PMID 19462250.

Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Ghoneim AM. Rapid pain relief using transdermal film forming polymeric solution of ketorolac. Pharm Dev Technol. 2013 Sep-Oct; 18(5):1005-16. Doi: 10.3109/10837450.2011.627867. PMID 22191998.

Vasia GL, T, Chavan VP, Chanaky M. Jm, H. Murthy. Pharm Sci Formulation (Topic). 2020. Development and Characterization of Novel Film Forming Polymeric Solution of Silver Sulfadiazine for Burn Wound Care.

Ranade SC, Bajaj AN, Londhe VY, Babul N, Kao D. Fabrication of topical metered dose film forming sprays for pain management. Eur J Pharm Sci. 2017; 100:132-41. Doi: 10.1016/j.ejps.2017.01.004, PMID 28069427.

Rajab. (2013, December). Preparation and Evaluation of ketoprofen as Dermal Spray Film. Kerbala Journal of Pharmaceutical Sciences.

Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery in Asian journal of Pharmaceutical Research; 2016. P. 4-5.

Karagianni A, Peltonen L. Production of itraconazole nanocrystal-based polymeric film formulations for immediate drug release. Pharmaceutics. 2020 Oct 13; 12(10):960. Doi: 10.3390/pharmaceutics12100960, PMID 33065968, PMCID PMC7600483

Basu B, Garala KC, Tyagi M, Prabhushankar GL, Babu PR. Formulation and in vitro evaluation of periodontal films containing metronidazole. Res J Pharm Dosage Forms Technol. 2009; 1:240-3.

Lu W, Luo H, Zhu Z, Wu Y, Luo J, Wang H. Preparation and the biopharmaceutical evaluation for the metered dose transdermal spray of dexketoprofen. J Drug Deliv. 2014; 2014:697434. Doi: 10.1155/2014/697434, PMID 24660066.

Kittaneh M, Qurt M, Malkieh N, Naseef HA, Muqedi RH. Preparation and evaluation of vitamin D3 supplementation as transdermal film-forming solution. Pharmaceutics. 2022; 15(1):VD3. Doi: 10.3390/pharmaceutics15010039, PMID 36678668.

Published

23-10-2024

How to Cite

DEHGHAN, M. H., and S. P. RAJPUT. “‘TECHNICAL AND PATENT PERSPECTIVE ON FILM FORMING TOPICAL SPRAYS’”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 16, no. 12, Oct. 2024, doi:10.22159/ijpps.2024v16i12.52109.

Issue

Section

Review Article(s)